110 related articles for article (PubMed ID: 22947894)
1. Kinetics and docking studies of two potential new inhibitors of the nucleoside hydrolase from Leishmania donovani.
Rennó MN; França TC; Nico D; Palatnik-de-Sousa CB; Tinoco LW; Figueroa-Villar JD
Eur J Med Chem; 2012 Oct; 56():301-7. PubMed ID: 22947894
[TBL] [Abstract][Full Text] [Related]
2. Cloning, expression, characterization and inhibition studies on trypanothione synthetase, a drug target enzyme, from Leishmania donovani.
Saudagar P; Dubey VK
Biol Chem; 2011 Dec; 392(12):1113-22. PubMed ID: 22050226
[TBL] [Abstract][Full Text] [Related]
3. Overexpression, purification, and characterization of S-adenosylhomocysteine hydrolase from Leishmania donovani.
Yang X; Borchardt RT
Arch Biochem Biophys; 2000 Nov; 383(2):272-80. PubMed ID: 11185563
[TBL] [Abstract][Full Text] [Related]
4. A nonspecific nucleoside hydrolase from Leishmania donovani: implications for purine salvage by the parasite.
Cui L; Rajasekariah GR; Martin SK
Gene; 2001 Dec; 280(1-2):153-62. PubMed ID: 11738828
[TBL] [Abstract][Full Text] [Related]
5. Isozyme-specific transition state inhibitors for the trypanosomal nucleoside hydrolases.
Parkin DW; Limberg G; Tyler PC; Furneaux RH; Chen XY; Schramm VL
Biochemistry; 1997 Mar; 36(12):3528-34. PubMed ID: 9132003
[TBL] [Abstract][Full Text] [Related]
6. Structure and function of a novel purine specific nucleoside hydrolase from Trypanosoma vivax.
Versées W; Decanniere K; Pellé R; Depoorter J; Brosens E; Parkin DW; Steyaert J
J Mol Biol; 2001 Apr; 307(5):1363-79. PubMed ID: 11292348
[TBL] [Abstract][Full Text] [Related]
7. Comparative inhibitory activity of 3'- and 5'-functionalized nucleosides on ribonuclease A.
Debnath J; Dasgupta S; Pathak T
Bioorg Med Chem; 2010 Dec; 18(23):8257-63. PubMed ID: 21041096
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of bicyclic N-arylmethyl-substituted iminoribitol derivatives as selective nucleoside hydrolase inhibitors.
Berg M; Bal G; Goeminne A; Van der Veken P; Versées W; Steyaert J; Haemers A; Augustyns K
ChemMedChem; 2009 Feb; 4(2):249-60. PubMed ID: 19115304
[TBL] [Abstract][Full Text] [Related]
9. The importance of nucleoside hydrolase enzyme (NH) in studies to treatment of Leishmania: A review.
Figueroa-Villar JD; Sales EM
Chem Biol Interact; 2017 Feb; 263():18-27. PubMed ID: 27939867
[TBL] [Abstract][Full Text] [Related]
10. N-Arylmethyl substituted iminoribitol derivatives as inhibitors of a purine specific nucleoside hydrolase.
Goeminne A; Berg M; McNaughton M; Bal G; Surpateanu G; Van der Veken P; De Prol S; Versées W; Steyaert J; Haemers A; Augustyns K
Bioorg Med Chem; 2008 Jul; 16(14):6752-63. PubMed ID: 18571422
[TBL] [Abstract][Full Text] [Related]
11. Kinetic characterization of inosine monophosphate dehydrogenase of Leishmania donovani.
Dobie F; Berg A; Boitz JM; Jardim A
Mol Biochem Parasitol; 2007 Mar; 152(1):11-21. PubMed ID: 17173987
[TBL] [Abstract][Full Text] [Related]
12. Novel multisubstrate inhibitors of mammalian purine nucleoside phosphorylase.
Toms AV; Wang W; Li Y; Ganem B; Ealick SE
Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1449-58. PubMed ID: 16239721
[TBL] [Abstract][Full Text] [Related]
13. Insights into nucleoside hydrolase from Leishmania donovani inhibition: A new bioaffinity chromatography-based screening assay and docking studies.
Anchau Wegermann C; Santana Bezerra E; Gomes de Macedo Sant'Anna I; Ortega De Oliveira PC; da Costa Silva R; Rocco Machado T; Wanderley Tinoco L; Vieira de Souza MCB; Pascutti P; Santos Boechat FDC; de Moraes MC
Bioorg Chem; 2024 May; 146():107302. PubMed ID: 38521010
[TBL] [Abstract][Full Text] [Related]
14. An insight into the mechanism of inhibition of unusual bi-subunit topoisomerase I from Leishmania donovani by 3,3'-di-indolylmethane, a novel DNA topoisomerase I poison with a strong binding affinity to the enzyme.
Roy A; Das BB; Ganguly A; Bose Dasgupta S; Khalkho NV; Pal C; Dey S; Giri VS; Jaisankar P; Dey S; Majumder HK
Biochem J; 2008 Jan; 409(2):611-22. PubMed ID: 17922678
[TBL] [Abstract][Full Text] [Related]
15. An NMR-Based Chemometric Strategy to Identify
Casanova LM; Rodrigues LM; de Aguiar PF; Tinoco LW
J Nat Prod; 2020 Feb; 83(2):243-254. PubMed ID: 31985226
[TBL] [Abstract][Full Text] [Related]
16. Competitive inhibition of human poly(A)-specific ribonuclease (PARN) by synthetic fluoro-pyranosyl nucleosides.
Balatsos NA; Vlachakis D; Maragozidis P; Manta S; Anastasakis D; Kyritsis A; Vlassi M; Komiotis D; Stathopoulos C
Biochemistry; 2009 Jul; 48(26):6044-51. PubMed ID: 19472977
[TBL] [Abstract][Full Text] [Related]
17. Glyoxalase I from Leishmania donovani: a potential target for anti-parasite drug.
Padmanabhan PK; Mukherjee A; Singh S; Chattopadhyaya S; Gowri VS; Myler PJ; Srinivasan N; Madhubala R
Biochem Biophys Res Commun; 2005 Dec; 337(4):1237-48. PubMed ID: 16236261
[TBL] [Abstract][Full Text] [Related]
18. Molecular docking, structure-activity relationship and biological evaluation of the anticancer drug monastrol as a pteridine reductase inhibitor in a clinical isolate of Leishmania donovani.
Kaur J; Sundar S; Singh N
J Antimicrob Chemother; 2010 Aug; 65(8):1742-8. PubMed ID: 20519355
[TBL] [Abstract][Full Text] [Related]
19. N-(1,3-Diaryl-3-oxopropyl)amides as a new template for xanthine oxidase inhibitors.
Nepali K; Agarwal A; Sapra S; Mittal V; Kumar R; Banerjee UC; Gupta MK; Satti NK; Suri OP; Dhar KL
Bioorg Med Chem; 2011 Sep; 19(18):5569-76. PubMed ID: 21862335
[TBL] [Abstract][Full Text] [Related]
20. Leishmania donovani pteridine reductase 1: biochemical properties and structure-modeling studies.
Kumar P; Kumar A; Verma SS; Dwivedi N; Singh N; Siddiqi MI; Tripathi RP; Dube A; Singh N
Exp Parasitol; 2008 Sep; 120(1):73-9. PubMed ID: 18617167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
